Cargando…

Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation

BACKGROUND: Medication regimen complexity (MRC) has not been characterized in detail in patients with end-stage renal disease (ESRD). The objective of the present study was to quantify changes over time in the prescription drug burden and MRC in patients with ESRD (before transplantation, on dischar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marienne, Justine, Laville, Solène M., Caillard, Pauline, Batteux, Benjamin, Gras-Champel, Valérie, Masmoudi, Kamel, Choukroun, Gabriel, Liabeuf, Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785410/ https://www.ncbi.nlm.nih.gov/pubmed/33426392 http://dx.doi.org/10.1016/j.ekir.2020.10.011

Ejemplares similares

Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study
por: Rey, Amayelle, et al.
Publicado: (2019)

Drugs associated with incident fragility fractures in kidney transplant recipients
por: Batteux, Benjamin, et al.
Publicado: (2022)

Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase(®))
por: Dernoncourt, Amandine, et al.
Publicado: (2022)

Risk factors for and characteristics of community‐ and hospital‐acquired drug‐induced acute kidney injuries
por: Rey, Amayelle, et al.
Publicado: (2022)

Early steroid withdrawal has a positive effect on bone in kidney transplant recipients: a propensity score study with inverse probability-of-treatment weighting
por: Batteux, Benjamin, et al.
Publicado: (2020)

Association between Uremic Toxin Concentrations and Bone Mineral Density after Kidney Transplantation
por: Batteux, Benjamin, et al.
Publicado: (2020)

Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic Review
por: Pluquet, Maxime, et al.
Publicado: (2022)

Use of the Capture-Recapture Method to Estimate the Frequency of Community- and Hospital-Acquired Drug-Induced Acute Kidney Injuries in French Databases
por: Rey, Amayelle, et al.
Publicado: (2022)

Impact of the corticosteroid indication and administration route on overall survival and the tumor response after immune checkpoint inhibitor initiation
por: Gaucher, Louis, et al.
Publicado: (2021)

Associations between dysbiosis-inducing drugs, overall survival and tumor response in patients treated with immune checkpoint inhibitors
por: Gaucher, Louis, et al.
Publicado: (2021)

Risk Factors for Bleeding in Hospitalized at Risk Patients With an INR of 5 or More Treated With Vitamin K Antagonists
por: Liabeuf, Sophie, et al.
Publicado: (2015)

Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins
por: Laville, Solène M., et al.
Publicado: (2021)

Adaptation and validation of an adverse drug reaction preventability score for bleeding due to vitamin K antagonists
por: Liabeuf, Sophie, et al.
Publicado: (2016)

Impact of the COVID-19 outbreak on the reporting of adverse drug reactions associated with self-medication
por: Gras, M., et al.
Publicado: (2021)

Potential interactions between uraemic toxins and drugs: an application in kidney transplant recipients treated with calcineurin inhibitors
por: André, Camille, et al.
Publicado: (2021)

Difference in Profiles of the Gut-Derived Tryptophan Metabolite Indole Acetic Acid between Transplanted and Non-Transplanted Patients with Chronic Kidney Disease
por: Liabeuf, Sophie, et al.
Publicado: (2020)

COVID-19 et vaccins à adénovirus : expérience française de suivi renforcé de pharmacovigilance
por: Massy, Nathalie, et al.
Publicado: (2023)

Economic Burden of ESRD to the Malaysian Health Care System
por: Ismail, Hirman, et al.
Publicado: (2019)

The Prescription of Drugs That Inhibit Organic Anion Transporters 1 or 3 Is Associated with the Plasma Accumulation of Uremic Toxins in Kidney Transplant Recipients
por: André, Camille, et al.
Publicado: (2021)

The Role of Gut-Derived, Protein-Bound Uremic Toxins in the Cardiovascular Complications of Acute Kidney Injury
por: Caillard, Pauline, et al.
Publicado: (2022)

Lower Mortality in Living Kidney Donors With ESRD Versus Matched Nondonors With ESRD
por: Muzaale, Abimereki D.
Publicado: (2018)

Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres
por: Gras-Champel, Valérie, et al.
Publicado: (2021)

Iron status in ESRD patients
por: Wiwanitkit, V.
Publicado: (2011)

The Tragedy of Having ESRD in Mexico
por: Garcia-Garcia, Guillermo, et al.
Publicado: (2018)

Protein Nutrition and Malnutrition in CKD and ESRD
por: Zha, Yan, et al.
Publicado: (2017)

Identification of ESRD in Cardiovascular Procedural Databases
por: Charytan, David M., et al.
Publicado: (2019)

COVID-19 infection recurrence in ESRD
por: Onuigbo, Macaulay A. C.
Publicado: (2022)

Ulceration of the oral mucosa following direct contact with ferrous sulfate in elderly patients: a case report and a review of the French National Pharmacovigilance Database
por: Liabeuf, Sophie, et al.
Publicado: (2014)

COVID-19 vaccines surveillance in France: a global response to a major national challenge
por: Benkebil, Mehdi, et al.
Publicado: (2021)

Consequences of oral antithrombotic use in patients with chronic kidney disease
por: Laville, Solène M., et al.
Publicado: (2021)

Urea levels and cardiovascular disease in patients with chronic kidney disease
por: Laville, Solène M, et al.
Publicado: (2022)

The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease
por: Liabeuf, Sophie, et al.
Publicado: (2015)

Renal Bone Disease Among Patients With ESRD
por: Beladi Mousavi, Seyed Seifollah, et al.
Publicado: (2013)

Patient Selection in the ESRD Managed Care Demonstration
por: Shapiro, Jennifer R., et al.
Publicado: (2003)

Evaluation of the ESRD Managed Care Demonstration Operations
por: Oppenheimer, Caitlin Carroll, et al.
Publicado: (2003)

ESRD Managed Care Demonstration: Financial Implications
por: Dykstra, Dawn M., et al.
Publicado: (2003)

Role of Renal Re-transplantation in ESRD Patients
por: Ghadian, Alireza, et al.
Publicado: (2013)

Agranulocytosis Induced by Vancomycin in an ESRD Patient on CAPD
por: Jo, Young-Il, et al.
Publicado: (2004)

Drug-Induced Thrombotic Microangiopathy Resulting in ESRD
por: Agarwal, Krishna A., et al.
Publicado: (2020)

COVID-19 in ESRD and Acute Kidney Injury
por: Kooman, Jeroen P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0gj1khednbkgi5flelmirgmcni